Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma

The incidence of renal-cell carcinoma has been increasing each year, with nearly one third of new cases diagnosed at advanced or metastatic stage. The advent of targeted therapies for metastatic renal-cell carcinoma (mRCC) has underscored the need to subtype tumors according to tumor-immune expressi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Genitourin Cancer
Hauptverfasser: Labriola, Matthew K., Batich, Kristen A., Zhu, Jason, McNamara, Megan A., Harrison, Michael R., Armstrong, Andrew J., George, Daniel J., Zhang, Tian
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004481/
https://ncbi.nlm.nih.gov/pubmed/30858035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2019.01.017
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge